Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support (original) (raw)

A comparison of the effects of three luteal phase support protocols with estrogen on in vitro fertilization-embryo transfer outcomes in patients on a GnRH antagonist protocol

Juliano Scheffer

JBRA Assisted Reproduction

View PDFchevron_right

Impact of GnRH agonist triggering and intensive luteal steroid support on live-birth rates and ovarian hyperstimulation syndrome: a retrospective cohort study

Stamatina Iliodromiti

View PDFchevron_right

GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles-A Systematic PRISMA Review and Meta-analysis

Sandro C Esteves

Frontiers in endocrinology, 2017

View PDFchevron_right

Natural Cycle IVF can be a successful treatment alternative for patients with low ovarian reserve

Markus Nitzschke

JBRA Assisted Reproduction, 2013

View PDFchevron_right

Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles

Ai Ai

Fertility and Sterility, 2014

View PDFchevron_right

Are pregnancy rates compromised following embryo freezing to prevent OHSS?

Neil McClure

The Ulster medical journal, 2008

View PDFchevron_right

A new treatment to avoid severe ovarian hyperstimulation utilizing insights from in vitro maturation therapy

Bruce Rose

Journal of Assisted Reproduction and Genetics, 2013

View PDFchevron_right

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study

Claudio Benadiva

Fertility and Sterility, 2008

View PDFchevron_right

A comparison of the effects of three different luteal phase support protocols on in vitro fertilization outcomes: a randomized clinical trial

Turgut Var

Fertility and Sterility, 2011

View PDFchevron_right

Pregnancy Rate in Frozen Cycles Transfer After Freeze-All Policy to Prevent Ovarian Hyper Stimulation Syndrome

walid elnaggar

The Egyptian Journal of Hospital Medicine, 2020

View PDFchevron_right

GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study

Shahar Kol

Human Reproduction, 2011

View PDFchevron_right

Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes

Claudio Benadiva

Fertility and Sterility, 2009

View PDFchevron_right

Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles

Manon Ziech

Protocols, 2005

View PDFchevron_right

Route of progesterone administration for luteal phase support may affect outcome of controlled ovarian hyperstimulation for IVF with ICSI using GnRH antagonist

ulun ulug

Journal of Assisted Reproduction and Genetics, 2008

View PDFchevron_right

Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels

Eleuterio Hernandez

Fertility and Sterility, 2010

View PDFchevron_right

Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks

B. Fauser, William Crowley

Human Reproduction, 1999

View PDFchevron_right

Freeze-all policy versus luteal phase support with low dose of human chorionic gonadotrophin for high-responder patients undergoing intracytoplasmic sperm injection on pregnancy outcomes: a retrospective cohort observational study

Ahmed Abdeltawab

Middle East Fertility Society Journal

View PDFchevron_right

Oocyte retrieval following continued stimulation five days beyond ovulation yields live birth after frozen embryo transfer

Lynn Westphal

Journal of Assisted Reproduction and Genetics, 2012

View PDFchevron_right

Ovarian Stimulation with FSH Alone versus FSH plus a GnRH Antagonist for Elective Freezing in an Oocyte Donor/Recipient Programme: A Protocol for a Pilot Multicenter Observational Study

Alexandros Daponte

Journal of Clinical Medicine

View PDFchevron_right

Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization

Ai Ai

Fertility and sterility, 2015

View PDFchevron_right

GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial

Yannis Panagiotidis

Journal of Assisted Reproduction and Genetics, 2017

View PDFchevron_right

Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates

Eleuterio Hernandez

Fertility and Sterility, 2006

View PDFchevron_right

Impact of changing the ovarian hyperstimulation protocol in the sequental cycle on ICSI outcomes in the same patient population

Berna Dilbaz

Journal of Gynecology Obstetrics and Human Reproduction, 2021

View PDFchevron_right

Elective cryopreservation of all embryos in women at risk of developing ovarian hyperstimulation syndrome may not prevent the condition but reduces the live birth rate

Awoniyi Awonuga

Journal of Assisted Reproduction and Genetics, 1996

View PDFchevron_right

Repeated Application of Luteal Phase Estradiol / GnRH Antagonist Priming Increases IVF Success for Poor Ovarion Reserve Patients

ULAŞ FİDAN

2022

View PDFchevron_right

ESHRE guideline: ovarian stimulation for IVF/ICSI†

Tanya Timeva

Human Reproduction Open, 2020

View PDFchevron_right

Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF.

Oybek Rustamov

Human Reproduction, 2011

View PDFchevron_right

Session 65: Fertility Preservation 3

P. Hassun

Human Reproduction, 2010

View PDFchevron_right

Alternative Approaches to Ovarian Stimulation and Triggering of Ovulation

Rubina Merchant

Jaypee Brothers Medical Publishers (P) Ltd. eBooks, 2018

View PDFchevron_right

High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol

Bernadette Mannaerts

Human Reproduction, 2013

View PDFchevron_right